Generic Skelaxin Moves Closer As King Loses Patent Case; Last Hurdle Is FDA

Following a win in its patent case against King, Sandoz appears to have only one hurdle remaining before it can launch a generic of Skelaxin (metaxalone) - FDA approval of its ANDA